Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

7.70
Delayed Data
As of 3:59pm ET
 -0.0999 / -1.28%
Today’s Change
4.76
Today|||52-Week Range
7.98
+29.41%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.80
Today’s open7.70
Day’s range7.58 - 7.70
Volume8,980
Average volume (3 months)10,221
Market cap$39.4M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio96.3
Price/Sales2.70
Price/Book1.92

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc+0.01+1.50%
APVOAptevo Therapeutics ...-0.02-0.84%
BPTHBio Path Holdings In...+0.00+0.90%
CANFCan Fite Biopharma L...-0.01-0.60%
Data as of 6:30pm ET, 10/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts